دورية أكاديمية
A Randomized Phase II Study of Eribulin/Cyclophosphamide or Docetaxel/Cyclophosphamide as Neoadjuvant Therapy in Operable HER2-negative Breast Cancer
| العنوان: | A Randomized Phase II Study of Eribulin/Cyclophosphamide or Docetaxel/Cyclophosphamide as Neoadjuvant Therapy in Operable HER2-negative Breast Cancer |
|---|---|
| المؤلفون: | Yardley, Denise A., Shipley, Dianna, Zubkus, John, Wright, Gail L., Ward, Patrick J., Mani, Aruna, Shastry, Mythili, Finney, Lindsey, DeBusk, Laura, Hainsworth, John D. |
| المصدر: | In Clinical Breast Cancer February 2019 19(1):1-9 |
| قاعدة البيانات: | ScienceDirect |
Full Text via ClinicalKey 
Full Text Finder | تدمد: | 15268209 |
|---|---|
| DOI: | 10.1016/j.clbc.2018.08.006 |